Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
1(8%)
Results Posted
89%(8 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_4
7
54%
Ph not_applicable
3
23%
Ph phase_2
1
8%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 4Post-market surveillance
7(58.3%)
N/ANon-phased studies
3(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(9)
Terminated(2)
Other(1)

Detailed Status

Completed9
Terminated2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 47 (58.3%)
N/A3 (25.0%)

Trials by Status

completed969%
recruiting18%
terminated215%
unknown18%

Recent Activity

1 active trials
Showing 5 of 13
terminatedphase_1

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

NCT04504331
recruitingphase_2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

NCT06411795
completednot_applicable

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

NCT04870645
completedphase_4

Adenosine Contrast CorrELations in Evaluating RevAscularizaTION

NCT03557385
completed

Study With Oral Isovue in Abdominopelvic CT

NCT04453059
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT04504331Phase 1

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Terminated
NCT06411795Phase 2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Recruiting
NCT04870645Not Applicable

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

Completed
NCT03557385Phase 4

Adenosine Contrast CorrELations in Evaluating RevAscularizaTION

Completed
NCT04453059

Study With Oral Isovue in Abdominopelvic CT

Completed
NCT05489055Not Applicable

Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA

Unknown
NCT01136876Phase 4

Kidney Damage in Patients With Moderate Fall in eGFR

Completed
NCT02433665Not Applicable

Customized Contrast Media Dose Clinical Trial

Terminated
NCT03384979Phase 4

Optimization of Contrast Agent Dose in CT With Lean Body Weight

Completed
NCT01475097Phase 4

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

Completed
NCT02040285Phase 4

Low-dose Laxative Improves Performance and Feasibility of Computed Tomography Colonography (CTC)

Completed
NCT01376089Phase 4

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

Completed
NCT01075217Phase 4

Isovue in Peripheral Digital Subtraction Angiography (DSA)

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13